Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
Department of Experimental Immunology, Academic Medical Centre, Amsterdam, The Netherlands.
Am J Transplant. 2017 Aug;17(8):2033-2044. doi: 10.1111/ajt.14279. Epub 2017 May 19.
Virus-specific T cells can recognize allogeneic HLA (allo-HLA) through TCR cross-reactivity. The allospecificity often differs by individual (private cross-reactivity) but also can be shared by multiple individuals (public cross-reactivity); however, only a few examples of the latter have been described. Because these could facilitate alloreactivity prediction in transplantation, we aimed to identify novel public cross-reactivities of human virus-specific CD8 T cells directed against allo-HLA by assessing their reactivity in mixed-lymphocyte reactions. Further characterization was done by studying TCR usage with primer-based DNA sequencing, cytokine production with ELISAs, and cytotoxicity with chromium-release assays. We identified three novel public allo-HLA cross-reactivities of human virus-specific CD8 T cells. CMV B35/IPS CD8 T cells cross-reacted with HLA-B51 and/or HLA-B58/B57 (23% of tetramer-positive individuals), FLU A2/GIL (influenza IMP[58-66] HLA-A02:01/GILGFVFTL) CD8 T cells with HLA-B38 (90% of tetramer-positive individuals), and VZV A2/ALW (varicella zoster virus IE62[593-601] HLA-A02:01/ALWALPHAA) CD8 T cells with HLA-B55 (two unrelated individuals). Cross-reactivity was tested against different cell types including endothelial and epithelial cells. All cross-reactive T cells expressed a memory phenotype, emphasizing the importance for transplantation. We conclude that public allo-HLA cross-reactivity of virus-specific memory T cells is not uncommon and may create novel opportunities for alloreactivity prediction and risk estimation in transplantation.
病毒特异性 T 细胞可以通过 TCR 交叉反应识别同种异体 HLA(allo-HLA)。同种异体特异性通常因个体而异(个体间的交叉反应),但也可以在多个个体中共享(公共交叉反应);然而,后者只有少数几个例子被描述过。因为这些可能有助于移植中的同种异体反应预测,所以我们通过评估混合淋巴细胞反应中的反应性,旨在通过评估其在混合淋巴细胞反应中的反应性来鉴定针对 allo-HLA 的人类病毒特异性 CD8 T 细胞的新的公共交叉反应性。通过使用基于引物的 DNA 测序研究 TCR 利用、ELISA 测定细胞因子产生以及铬释放测定测定细胞毒性来进一步进行特征描述。我们鉴定了三种针对人类病毒特异性 CD8 T 细胞的新的公共 allo-HLA 交叉反应性。CMV B35/IPS CD8 T 细胞与 HLA-B51 和/或 HLA-B58/B57(23%的四聚体阳性个体)发生交叉反应,FLU A2/GIL(流感 IMP[58-66] HLA-A02:01/GILGFVFTL)CD8 T 细胞与 HLA-B38(90%的四聚体阳性个体)发生交叉反应,而 VZV A2/ALW(水痘带状疱疹病毒 IE62[593-601] HLA-A02:01/ALWALPHAA)CD8 T 细胞与 HLA-B55(两个无关个体)发生交叉反应。对包括内皮细胞和上皮细胞在内的不同细胞类型进行了交叉反应性测试。所有交叉反应性 T 细胞均表达记忆表型,强调了其在移植中的重要性。我们的结论是,病毒特异性记忆 T 细胞的公共 allo-HLA 交叉反应性并不罕见,并且可能为移植中的同种异体反应预测和风险评估创造新的机会。